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THE GENETIC AMYLOIDOSES WITH SPECIAL EMPHASIS ON 
FAMILIAL MEDITERRANEAN FEVER"^  
EZRA SOHAR, M.D.** 
I T IS A GREAT pleasure to talk about Famihal Mediterranean Fever (FMF) here in 
Detroit where the disease is familiar to physicians. Therefore, I will not go into 
details about the clinical picture of the disease, which I trust you know as well as 
we. I shall talk about FMF as one of the genetic amyloidoses and stress in passing 
only those clinical aspects which apparently are more obvious in Israel. 
By way of introduction, I would like to say a word about the incidence of 
amyloidosis. Usually considered a rare disease, it has been reported in between 0.5 
to 0.8 per cent of autopsies. However, we have recently taken blocks of 200 con-
secutive autopsies at our hospital, in which amyloidosis was not diagnosed, and 
among these found amyloid deposits in 28 including two cases of generalized amy-
loidosis. I would also like to recall the experience of Dr. Teilum, Professor of 
Pathology in Copenhagen.= On reviewing, from his own department, 28 autopsied 
cases of rheumatoid arthritis in whom the diagnosis of amyloidosis had been made 
in only 3 he found amyloid in 14 additional ones. This proves that amyloid is not 
just found; it must be looked for, and when looked for, it is not so rare after all. 
The true incidence of amyloidosis is certainly much higher than has been suspected. 
One reason we found more cases than usual is a technique which we learned 
from Dr. Hans-Peter Missmahl of Tubingen, Germany." This calls for the staining of 
amyloid tissue by Congo red and examining with the polarized-hght microscope. With 
this technique, we frequently were able to identify with certainty amyloid deposits 
not detectable by ordinary microscopy and thus to establish the diagnosis of amyloidosis. 
This was of special help in the examination of biopsy material. 
When a physician thinks or speaks about amyloidosis he usually conceives of 
it as being secondary to some chronic infectious or inflammatory disease. When we 
encountered our first FMF patient with amyloidosis, it seemed logical to assume 
that the amyloidosis was secondary to the many attacks of fever he had suffered. 
*Presented before the Henry Ford Hospital Tuesday Morning Medical Staff Meeting, March 3, 1964. 
Supported in part by USPHS, National Institutes of Health Research Grant A-2857. 
**Tel-Hashomer Hospital, Clinical Research Laboratory, FMF Unit, Israel. 
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However, it was not long before amyloidosis was found in another patient very shortly 
after the onset of his attacks, and finally our experience broadened to include a 
patient who had never had attacks (his brother suffered from attacks) and in whom 
amyloidosis appeared as the sole manifestation of FMF. These observations led to 
the conclusion that the amyloidosis in FMF is not secondary but hereditary. 
There are today five entities of genetic amyloidosis and it is likely that in the 
future additional entities will be described. This morning I shall review the genetic 
amyloidoses described so far and suggest some sort of classification. 
The inherited amyloidoses are systemic involving all organs of the body with 
few exceptions. Nevertheless, the disease usually becomes manifest clinically through 
the more massive involvement of one organ. Accordingly, they can be divided 
into three types: the nephropathic types in which the main symptoms and signs arc 
those of renal disease; the neuropathic forms in which peripheral neuropathy is the 
principal feature; the cardiopathic type which is marked by intractable heart failure. 
I shall start with FMF which is a nephropathic amyloidosis. FMF is an 
ethnically restricted disease. As you know, the Jewish population is divided in its 
ethnic origin into Ashkenazi and Sephardi Jews. In Israel, each of these groups 
comprises about 50 per cent of the population. Nevertheless, our 400 patients include 
only nine Ashkenazi, all the others being Sephardi Jews who derive from various 
countries around the Mediterranean; there are five Arabs, all born in Israel. It is 
not so astonishing that most of our patients in Israel are Jews. However, a review 
of the literature will show that the largest group (more than 50 per cent) are again 
non-Ashkenazi Jews; the remainder include a large group of Armenians, a small group 
of Arabs and sporadic cases of other origins. Al l of them derive from Mediterranean 
countries. 
A disease which is ethnically restricted, unless it is due to some infectious or 
nutritional factor, is usually a genetic disease. In FMF we have shown that the 
disease is transmitted as a complete autosomal recessive. A positive family history 
was obtained in 229 of 400 patients and a questionable one in 75. In the vast 
majority of cases only sibs are affected, and we find that of 215 marriages producing 
FMF offspring, 42 were cousin marriages. Thus, we find all the characteristics of 
recessive inheritance, as has also been shown by other techniques. The gene frequency 
is 0.02 in the Sephardi Jewish population. 
FMF becomes clincially manifest very early in life. By the age of 15, about 
two-thirds of the patients are already affected and by the age of 20, more than 30 
per cent. It seems likely that most of the remainder probably experience some sort 
of attacks in childhood, but the disease is not recognized at that time. It is of 
interest to note that our youngest patient developed his first attack when one month old. 
The attacks of FMF consist of short bouts of fever accompanied by abdominal 
pain, by chest pain or by joint manifestations. Although attacks as a rule subside in 
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24-48 hours, we have observed rather frequently the protraction of a usual joint 
attack into a chronic monoarthritis, which may persist for weeks and even months. 
It is a characteristic feature of the arthritis of FMF that even if the patient develops 
hydroarthrosis and is immobilized for weeks or months, the inflammatory changes 
eventually resolve and the patient regains complete use of his joints. Another feature 
which I believe is characteristic of FMF is a skin manifestation which we call 
erysipslas-like erythema. It usually appears in the ankle region, frequently after 
strenuous exercise, and subsides in 12 to 24 hours. 
As to the amyloidosis, we have examined 330 patients. Of these, 53 have died 
of amyloidosis while 50 are living today with nephropathy; in 23 of the later amyloid 
has been demonstrated by rectal biopsy.''^ '^  
The duration of the nephropathy from the time of diagnosis to death is usually 
6 to 10 years. There is a large group who died earlier, but these came under 
observation when they already had progressive renal disease. We know today that 
there is a pre-clinical stage of amyloidosis. In one of our patients kidney biopsy was 
performed and found positive for amyloid, in spite of the fact that she presented 
no clinical or laboratory evidence of renal disease or other manifestations of amyloidosis. 
Three years passed from the time of biopsy to the appearance of proteinuria. There 
is, therefore, a prolonged pre-clinical stage in amyloidosis of FMF and probably in 
the others as well. 
Most of our patients are very young. Two-thirds are below the age of 30, and 
80 percent below 35. The age of death from amyloidosis is also very ea.rly. Our 
youngest patient was six years old when he died. It is interesting to note that the 
cause of death in all of our FMF patients was amyloidosis, except for one who was 
killed in a road accident. 
We now have five patients who have never shown attacks of FMF prior to the 
appearance of amyloidosis. However, each of them has a sibling or offspring who 
shows classical FMF attacks. We believe that there are two phenotypes of FMF: 
Phenotype I , in which attacks precede the onset of amyloidosis and phenotype I I , 
in which amyloidosis appears first and clinical attacks appear later or not at all. 
A few years ago, Drs. Muckle and Wells' from England described a family in 
which 9 of 18 members in three generations were affected by a curious disease 
characterized by bouts of fever, urticarial skin rash, progressive deafness and renal 
disease due to a.myloidosis. The transmission in this family was a dominant one, 
death occurring from renal failure between the ages of 40 to 45. This then is the 
other example of nephropathic genetic amyloidosis. 
A myocardiopathic amyloidosis was described in Denmark last year in a family 
in which 8 of 12 siblings were affected. Fatigue, dyspnea and intractable heart failure 
appeared between the ages of 40 and 50. The patients died two to five years after 
the onset of symptoms. Transmission is probably dominant. 
345 
SOHAR 
Two types of neuropathic amyloidosis are known today. One has been described 
by various Portugese authors, notably Andrade and Horta,' who have observed to 
date more than 100 cases. In those affected, a dominantly transmitted gene causes 
severe manifestations leading, after five years, to death. The manifestations are pre-
dominantly of a peripheral neuropathy affecting first and most severely the lower 
extremities, and later the gastrointestinal tract. 
Another form of neuropathy has been reported from America by Rukavina and 
his group.' Manifestations start in the upper extremities often with a carpal tunnel 
syndrome, and the disease, which is also dominantly transmitted, progresses much 
more slowly than the Portugese variety. An interesting and probably pathognomonic 
feature is the presence of opacities composed of amyloid material in the vitreous 
body of the eye. 
An enumeration of the genetic amyloidoses according to their presentation as 
nephropathy, cardiopathy or neuropathy is presented in Table I . ' 
FMF and the Portuguese form of amyloid neuropathy are ethnically restricted. 
It is also of interest to note that the cardiopathy and the two neuropathies produce 
symptoms which are due exclusively to amyloid deposition in the tissues; whereas, 
in the nephropathic forms (FMF and the syndrome of Muckle and Wells) there are 
pleiotropic manifestations of the gene. These are symptoms and signs which are 
independent characters of the mutant gene but are not directly related to the formation 
of amyloid. 
I must say a few words concerning the histology of amyloidosis. We all know, 
I am sure, the classical distinctions between typical and atypical amyloidosis, which 
assume that typical amyloidosis is of the secondary type and atypical the primary 
type. This has been used in various classifications, but in practice it has been shown 
that there is no close correlation between primary and atypical on the one hand, 
or typical and secondary on the other. 
Table I 
THE GENETIC AMYLOIDOSES 
Clinical 
Varieties 
Histological 
type 
NEPHROPATHY 
1. Familial Mediterranean Fever 
a) Phenotype I : 
Attacks first 
b) Phenotype I I : 
Amyloidosis first 
2. Fever, rash, and deafness 
CARDIOPATHY 
NEUROPATHY 
1. Legs most affected 
2. Arms most affected 
Peri-reticulin 
Peri-collagen 
Mode of 
inheritance 
Ethnic 
predilection 
Recessive 
Dominant 
" (?) 
Mediterranean Jews 
and Armenians 
Portuguese 
None 
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We have examined 70 cases of amyloidosis of the various syndromes including 
all five genetic entities. This was carried out a short time after Dr. Missmahl 
published two cases of amyloidosis in which he claimed that in each the mode of 
deposition of amyloid was different histologically. The difference is this: In one 
case he found the amyloid deposited close to the lumen of the arterioles, in the 
intima and the media, where reticulin fibers are usually very numerous. In the 
second he found amyloid mainly in the adventitia where collagen fibers normally 
predominate. We examined, as I said, 70 cases with him at our laboratory and 
came to the conclusion that not only has every case of amyloidosis either a "peri-
reticulin" or a "peri-collagen" distribution, but also every clinical entity of amyloidosis 
is homogeneous in this respect, belonging either to one or the other group. 
Amyloidosis is a disease of tissue systems and is not limited to specific organs. 
In the one variety, amyloid is deposited throughout the body where reticulin fibers 
are numerous; whereas, in the other the collagen fiber is primarily affected. 
Fig. 1. is a graphic description of the two varieties. It shows that peri-reticulin 
amyloid is initially deposited in the intima and later spreads centrifugally. Peri-
collagen amyloid is first deposited in the adventitia and spreads centripetally, leaving 
the intima free. 
Perl-
Reticular 
Deposition 
Perl-
CoUaqen 
Deposition 
Figure 1 
The vascular lesion in peri-reticulin and peri-collagen amyloidosis (reproduced from Harefuah 
64:41, 1963). (White line behind the arrow indicates site of the initial amyloid deposition.) 
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As to the classification of amyloidosis, our suggestion is based upon histological 
and etiological criteria (Table I I ) . Of the genetic amyloidoses, two are of peri-reticulin 
and three of peri-collagen distribution. Of the various entities of secondary or acquired 
amyloidosis, all except that of multiple myeloma and macroglobulinemia are of the 
peri-reticulin variety. The idiopathic forms include those cases in which no lesion 
other than amyloidosis was found on autopsy, and the etiology is unknown. 
We urge that a distinction be made between "primary" and "idiopathic amyloidosis. 
Primary should best be an anatomopathological term only, connoting no more than 
that amyloidosis is the sole autopsy finding. A case of primary amyloidosis may be 
of known or unknown etiology. If it is a genetic amyloidosis, etiology is known 
though pathogenesis is not. It is probable that many cases of so-called idiopathic 
primary amyloidosis are sporadic examples of the genetic type. In such cases, a 
complete family history and evaluation of a pedigree is indicated and sometimes, as 
has happened, a genetic amyloidosis will be established. 
SUMMARY 
The pathogenesis of amyloidosis is still unknown. It has been variously assumed 
to be due to antigen-antibody reaction, to various deposits from the blood, and so on. 
None of these theories have been proved. I would like to conclude with a few 
words regarding our hypothesis on the pathogenesis of amyloidosis, which is based, 
mainly on 3 facts: 
1) Amyloid occurs throughout the body in connective tissue and has never 
been found in any other tissue. 
2) Amyloid is a fibrous protein, as has been proved by polarized-light and 
electron microscopy. 
3) Amyloid is initially deposited in relation to pre-existing connective fibers, 
either reticulin or collagen. 
Table I I 
CLASSIFICATION OF THE AMYLOIDOSES 
PERI-RETICULAR PERI-COLLAGEN 
Hereditary Familial Mediterranean Fever 
Urticaria and Deafness (Muckle & Wells) 
Neuropathic (Rukavina et al) 
Neuropathic (Andrade: Horta) 
Cardiopathic (Frederiksen et al) 
Acquired Assoc. with Chronic Infection (tuberculosis, 
osteomyelitis, etc.). 
Chronic Inflammation of Unknown 
Etiology (Rheumatoid arth., etc.). 
Malignant Neoplasms 
Assoc. with Multiple Myeloma 
Idiopathic Nephropathic ("typical distribution") "Classical" Primary 
Neuropathic 
Cardiopathic 
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Therefore we believe that amyloid is in some way related pathogeneticaly to 
the connective tissue and to the normal ribrous proteins — probably reticulin and 
collagen. It is tempting to assume that amyloidosis is an aberration of those cells, 
which in health form the normal fibrous proteins and go astray as the result of 
some inborn or acquired defect and form amyloid. Of course, this is speculation 
awaiting proof. We do believe, however, that the recognition of five clear-cut entities 
of genetic amyloidosis will certainly be helpful in the concept and also in the final 
elucidation of the pathogenesis of amyloidosis. 
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